Factors Influencing the Development of Immune‐Complex Diseases
Open Access
- 1 November 1981
- Vol. 36 (8) , 527-535
- https://doi.org/10.1111/j.1398-9995.1981.tb01870.x
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Mediation of increased vascular permeability after complement activation. Histamine-independent action of rabbit C5a.The Journal of Experimental Medicine, 1981
- Phagocytosis and degradation of DNA‐anti‐DNA complexes by human phagocytes. II. Influence of the size of the complexesEuropean Journal of Immunology, 1980
- Binding sites for immune complexes containing IgG in the renal interstitiumClinical Immunology and Immunopathology, 1979
- The origin, kinetics, and characteristics of the kupffer cells in the normal steady stateThe Journal of Experimental Medicine, 1978
- Prolonged complement activation in miceKidney International, 1978
- Immunoglobulin classes of DNA binding activity in serum and skin in systemic lupus erythematosus.Journal of Clinical Investigation, 1977
- The in Vivo Metabolism of the Third Component of Complement in Systemic Lupus ErythematosusArthritis & Rheumatism, 1977
- Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis.Journal of Clinical Investigation, 1977
- Reduction of phagocytosis and lysosomal enzyme release from human leukocytes by serum from patients with systemic lupus erythematosusArthritis & Rheumatism, 1976
- STUDIES ON CIRCULATING IMMUNE COMPLEXESThe Journal of Experimental Medicine, 1968